There is a lot of hype regarding CBD and a lack of regulatory clarity. I discuss the big issues and identify some of the better players in the space among public-traded companies.
Cannabidiol has taken off lately, and the recent passage of the Farm Act in December has accelerated interest in the cannabinoid found in cannabis plants that was also the active ingredient in the first FDA approved drug derived from botanical cannabis, GW Pharmaceuticals's Epidiolex, which is indicated for the treatment of seizures in treatment-resistant forms of two types of epilepsy, Dravet syndrome and Lennox-Gastaut syndrome.
The recent Farm Act that legalized industrial hemp was supposed to clear the path for the sale of CBD from industrial hemp, but this is only at the federal level. It turns out that states must create legislation to govern hemp production and the commercialization of hemp.
Gottlieb had recently announced that the agency would hold public hearings on the issue in April. His pending departure throws into question how this will all play out, so uncertainty will persist for a while.With the tremendous growth in the market, investors have expressed keen interest in CBD, and the number of publicly-traded stocks has skyrocketed.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Cannabis stocks tumble as FDA chief’s departure leaves CBD regulation in limboCannabis stocks fall as investors weigh the surprise news that the head of the U.S. Food and Drug Administration has resigned, leaving the fate of the cannabis ingredient CBD in regulatory limbo.
Weiterlesen »
With CBD, Cannabis Wellness Market Goes BigSales of CBD are predicted to hit $22 billion in 3 years—and much of that projected growth is coming from CBD’s newly minted status as a health and wellness product
Weiterlesen »
FDA chief Scott Gottlieb's resignation leaves 'billion-dollar question' for CBD industryJust a week ago, it looked like the Food and Drug Administration was ready to revisit its policies around CBD-infused food and drinks.
Weiterlesen »
This investing app lets anyone with $50 invest in companies that make money by doing goodSwell is an impact investing app that's based on the idea that today’s biggest challenges will result in tomorrow’s leading industries.
Weiterlesen »
Closing Central Madrid To Cars Resulted In 9.5% Boost To Retail Spending, Finds Bank AnalysisCity of Madrid significantly boosted the takings of its shops and restaurants last Christmas by banning cars from the CBD, finds an analysis by Spain's second largest bank.
Weiterlesen »
FDA chief Gottlieb resigns as agency battles teen vaping, opioid crisisFDA Commissioner Scott Gottlieb announced his resignation yesterday after having launched an aggressive campaign against teen smoking and the opioid crisis during his time in the post. The announcement came as a surprise to many.
Weiterlesen »
Cannabis stocks tumble as FDA chief’s departure leaves CBD regulation in limboCannabis stocks fall as investors weigh the surprise news that the head of the U.S. Food and Drug Administration has resigned, leaving the fate of the cannabis ingredient CBD in regulatory limbo.
Weiterlesen »
How New Jersey Is Offering Opportunity Through Tuition-Free Community CollegeMy state is walking the walk through the development and implementation of a new tuition-free community college program: the New Jersey Community College Opportunity Grant.
Weiterlesen »